Otsuka Holdings
4578.T
#615
Rank
โ‚ฌ36.84 B
Marketcap
70,33ย โ‚ฌ
Share price
0.29%
Change (1 day)
49.68%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

Revenue for Otsuka Holdings (4578.T)

Revenue in 2026 (TTM): โ‚ฌ14.73 Billion

According to Otsuka Holdings 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ15.32 Billion. In 2025 the company made a revenue of โ‚ฌ14.05 Billion a decrease over the revenue in the year 2024 that were of โ‚ฌ14.64 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Otsuka Holdings from 2010 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚ฌ14.73 B4.81%
2025 โ‚ฌ14.05 B-4%
2024 โ‚ฌ14.64 B13.98%
2023 โ‚ฌ12.84 B5.63%
2022 โ‚ฌ12.16 B3.08%
2021 โ‚ฌ11.79 B8.07%
2020 โ‚ฌ10.91 B-4.52%
2019 โ‚ฌ11.43 B11.7%
2018 โ‚ฌ10.23 B11.17%
2017 โ‚ฌ9.20 B-11.62%
2016 โ‚ฌ10.41 B-4.89%
2015 โ‚ฌ10.95 B
2013 โ‚ฌ10.23 B-5.39%
2012 โ‚ฌ10.81 B-1.73%
2011 โ‚ฌ11.00 B14.52%
2010 โ‚ฌ9.61 B